Shukra Pharmaceuticals Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was INR 588.34 million compared to INR 204.86 million a year ago. Revenue was INR 600.3 million compared to INR 205.67 million a year ago.

Net income was INR 44.07 million compared to INR 7.51 million a year ago. Basic earnings per share from continuing operations was INR 6.5525 compared to INR 1.1975 a year ago. Diluted earnings per share from continuing operations was INR 6.5525 compared to INR 1.1975 a year ago.